Evidence-based recommendations on SonoVue (sulphur hexafluoride microbubbles) for contrast-enhanced ultrasound imaging of the liver
Evidence-based recommendations on SeHCAT (tauroselcholic [75selenium] acid) for diagnosing bile acid malabsorption in people with IBS-D or Crohn’s disease
Evidence-based recommendations on multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis
Evidence-based recommendations on new generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac
Evidence-based recommendations on faecal immunochemical tests (OC Sensor, HM-JACKarc, FOB Gold and RIDASCREEN) to guide GP referral for colorectal cancer
Evidence-based recommendations on tests in secondary care to identify people at high risk of ovarian cancer. The tests are the IOTA ADNEX model, Overa (MIA2G)
Evidence-based recommendations on rapid tests for group A streptococcal infections in people aged 5 and over with a sore throat
Evidence-based recommendations on tests to help assess risk of acute kidney injury for people being considered for critical care admission. The tests are the
Evidence-based recommendations on high-sensitivity troponin tests for the early rule out of NSTEMI (non-ST-segment elevation myocardial infarction)
Evidence-based recommendations on implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke
Evidence-based recommendations on testing strategies for Lynch syndrome for people with endometrial cancer
Evidence-based recommendations on lead-I electrocardiogram (ECG) devices (imPulse, Kardia Mobile, MyDiagnostick and Zenicor-ECG) for detecting symptomatic
Evidence-based recommendations on enzyme-linked immunosorbent assay (ELISA) tests for therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors in
Evidence-based recommendations on point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast. The tests are
NICE has assessed 3 viscoelastometric point-of-care testing devices (the ROTEM, TEG and Sonoclot systems), to help the NHS decide whether to use these products
Evidence-based recommendations on the My5-FU assay for measuring levels of 5-flurouracil (5-FU) in patients having chemotherapy, to help guide changes to the
Evidence-based recommendations on 3 electroencephalography (EEG)-based depth of anaesthesia monitors for assessing a patient’s response to anaesthetic drugs
Evidence-based recommendations on the RD-100i OSNA system and Metasin test for detecting sentinel lymph node metastases in people having breast cancer surgery
Evidence-based recommendations on testing for epidermal growth factor receptor tyrosine kinase (EGFR–TK) mutations in untreated, locally advanced or metastatic
Evidence-based recommendations on therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors (LISA-TRACKER, IDKmonitor and Promonitor ELISA kits)
In development [GID-IP1046] Expected publication date: TBC
In development [GID-IPG10171] Expected publication date: TBC
In development [GID-IPG10172] Expected publication date: TBC
In development [GID-IPG10067] Expected publication date: TBC
In development [GID-IPG10137] Expected publication date: 27 January 2021
In development [GID-IPG10154] Expected publication date: TBC
In development [GID-IP1180] Expected publication date: TBC
In development [GID-IPG10158] Expected publication date: TBC
In development [GID-IPG10159] Expected publication date: TBC
In development [GID-IPG10160] Expected publication date: TBC
In development [GID-IPG10161] Expected publication date: TBC
In development [GID-IPG10163] Expected publication date: TBC
In development [GID-IPG10165] Expected publication date: TBC
In development [GID-IPG10166] Expected publication date: TBC
In development [GID-IPG10181] Expected publication date: TBC
In development [GID-IPG10179] Expected publication date: TBC
In development [GID-IPG10180] Expected publication date: TBC
In development [GID-IP2806] Expected publication date: TBC
In development [GID-IPG10153] Expected publication date: TBC
In development [GID-IP1238] Expected publication date: TBC
In development [GID-IP2803] Expected publication date: TBC
In development [GID-IPG10176] Expected publication date: 27 January 2021
In development [GID-IPG10138] Expected publication date: 03 March 2021
In development [GID-IPG10148] Expected publication date: 03 March 2021
In development [GID-IPG10146] Expected publication date: 03 March 2021
In development [GID-IPG10168] Expected publication date: TBC
In development [GID-IPG10169] Expected publication date: TBC
In development [GID-IPG10170] Expected publication date: TBC
In development [GID-IPG10152] Expected publication date: TBC
In development [GID-IP1131] Expected publication date: TBC